Semaglutide is the generic name of Ozempic. It's a type 2 diabetes medication manufactured by Novo Nordisk. Although it's used to treat diabetes, Ozempic is also marketed as a weight management medication. Novo Nordisk also offers two other forms of semaglutide. Wegovy and Rybelsus.
This form of medication is a glucagon-like peptide (GLP-1) Receptor Agonist. It helps regulate blood sugar and appetite, among other things. It has come to light in recent years that GLP-1 RAs can also result in serious medical conditions, including gastroparesis, vision loss, and bowel obstruction. These are lifelong conditions that affect your livelihood and how you live. People are now taking manufacturers like Novo Nordisk to court over these medical conditions.
There are over 1,300 pending lawsuits against semaglutide manufacturers as of February 2025. If you're suffering from gastroparesis, vision loss, or bowel obstruction, and it's because of semaglutide, reach out to us now. Our team will assess your case, and if it's eligible for a claim, we'll put you in touch with an attorney who specializes in matters like these.